https://hls831inhibitor.com/sa....rs-cov-2-infection-i
Even with recent breakthroughs in neoadjuvant chemo-immunotherapy, positive responses to the treatment protocol incorporating ICIs and chemotherapy are not universal, and some patients may experience severe immune-related adverse effects (irAEs). Analogous to the selection of patients for targeted therapies, determining which patients are most likely to gain from chemo-immunotherapy is of considerable importance. Recent research has highlighted multiple prognostic and predictive indi
লাইক
মন্তব্য করুন
শেয়ার করুন
